Return Home

IA2030 Scorecard

— Global View

  • Type to select a Country

Impact Goal 2: Promote Equity
2.2

Provide access to all vaccines

What Does this Indicator Measure?

Introduction of new or underutilized vaccines in low- and middle-income countries.

How Will Progress be Measured?

The target is 500 vaccine introductions in low- and middle-income countries by 2030, including current new or under-utilized vaccine introductions (NUVI) as well as vaccines that will be recommended over the decade. Progress will be evaluated annually.

Introduction of new or underutilized vaccines in low- and middle-income countries—Global

Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030

On track towards 2030 target

Summary Table

Vaccine introductions20202021
Total28167
Covid4127
DTP Booster02
HepB BD10
HiB00
HPV45
IPV2417
PCV25
Rotavirus44
Rubella00
Cholera00
Hep A10
Influenza53
JE00
MenA01
Multivariant Men00
Mumps10
Rabies00
Typhoid00
Varicella00
Yellow Fever00
MCV223
Definition: Introductions are defined as addition of a vaccine to the national immunization schedule and use of the vaccine for a sustained period of at least 12 months (excludes vaccines used only in the private sector that are not in national immunization schedule; includes vaccines in national immunization schedules that are used in at-risk populations, e.g., seasonal influenza).

New or underutilized vaccines are defined as vaccines that have not yet been introduced into national immunization schedules in all countries where recommended by WHO.

Measurement approach: Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in all countries: HepB birth dose, Hib, HPV, IPV2, MCV2, PCV, rotavirus, rubella, DTP booster (currently reporting the fourth dose at any age), and COVID-19 (interim recommendation). Vaccines included in this indicator that are recommended by WHO for use in national immunization schedules in countries in certain geographic region(s), in some high-risk populations, or in immunization programmes with certain characteristics: YF, JE, MenA, multivariate meningitis, typhoid, cholera, dengue, rabies, HepA, influenza, varicella, and mumps.
Calculation: Count of the number of country vaccine introductions for WHO recommended vaccines reported from 2021-2030.
Data source: WHO/UNICEF Joint Reporting Form on Immunization (JRF)